Dr. Ningli Wang

Dr. Wang Ningli is an ophthalmologist, a professor, and a holder of a doctoral degree. He currently serves as the director of Beijing Tongren Eye Center and the director of the National Engineering Research Center for Ophthalmic Diagnosis and Treatment in China. He is also a fellow of the International Academy of Ophthalmology and a former chair of the Asia–Pacific Academy of Ophthalmology. He has been consistently included in the "China Highly Cited Scholars" list by Elsevier for nine consecutive years, and was recently elected as the president-elect of the World Glaucoma Association. Dr. Wang has long been dedicated to research in the diagnosis and treatment technologies for glaucoma, a primary and irreversible blinding eye disease, as well as major eye disease prevention and control on a national scale. He has published 312 SCI papers as the first or corresponding author and has an H-index of 61. Among these publications, 31 papers (with 10 as the corresponding author) have been published in leading journals and sub-journals, such as Nature, JAMA, and Lancet. He has received two second-class national science and technology progress awards and five first-class provincial and ministerial awards as the first author.